2018 was a year of important wins. With
health care at the forefront of political debates on Capitol Hill as well as
the midterm election, OGR worked hard to continue to ensure that physician
priorities–including medical liability reform, ownership issues, and IPAB
repeal–were heard and advanced. Below is a list of some accomplishments
achieved during 2018-2019.
Sports Medicine Licensure Clarity Act and the Medical Controlled Substances Transportation Act
The Sports Medicine Licensure Clarity Act (H.R.302), was signed into law on Oct. 5, 2018, after more than five years of tireless advocacy. The legislation, which originated from AAOS, provides legal protection for traveling team physicians and safeguards injured athletes’ timely access to health care professionals who best know their medical histories.
Specifically, the law mandates that liability insurance of a medical professional treating their team in a secondary state should cover that person (subject to premium adjustments) as if treatment was provided in the primary state. Additionally, if two states do not currently have an agreement to provide licensure reciprocity, the provider is to be treated as if they’re practicing in the state in which they’re licensed.
For more on these issues, visit: www.aaos.org/advocacy/mlr/
To read the AAOS Now article, visit: www.aaos.org/AAOSNow/2018/Dec/Cover/cover01/?ssopc=1
Federal Appropriations FY 2018 and FY 2019
In February 2018, Congress passed legislation that includes an additional $2 billion in funding for the National Institutes of Health (NIH) requested by AAOS (read more here and here), another extension of the Children’s Health Insurance Program (CHIP) funding, and further funding to address the opioid epidemic.
The Senate version includes the $39.1 billion for the NIH (the number that passed out of Committee), which represents a $2 billion (5.4%) increase from the FY 2018 funding level as well as $711 million for implementation of the 21st Century Cures Act. The HHS Appropriations report language also includes language to support the development and utilization of Qualified Clinical Data Registries as part of the Center for Medicare and Medicaid Innovation’s purpose of testing innovative payment and service delivery models.
For more on these issues, visit: www.aaos.org/advocacy/researchappropriations/
Bipartisan Budget Act: MACRA and Independent Payment Advisory Board (IPAB)
The Bipartisan Budget Act of 2018, signed into law on Feb. 9, 2018, made technical amendments to improve MACRA, including a number of encouraging updates to MACRA requested by AAOS. For example, the legislation excludes Medicare Part B drug costs from MIPS payment adjustments and from the low-volume threshold determination; eliminates improvement scoring for the cost performance category for the third, fourth, and fifth years of MIPS; allows CMS to reweight the cost performance category to not less than 10 percent for the third, fourth, and fifth years of MIPS; and allows CMS flexibility in setting the performance threshold for years three through five to ensure a gradual and incremental transition to the performance threshold set at the mean or median for the sixth year. The legislation also permanently repeals the outpatient therapy caps beginning on Jan. 1, 2018, and removes the current mandate that meaningful use standards become more stringent over time. This eases the burden on physicians as they would no longer have to submit and receive a hardship exception from HHS.
also permanently repeals the Independent Payment Advisory Board, extends
CHIP funding for an additional four years, permanently repeals outpatient
therapy caps beginning Jan. 1, 2018, and removes current meaningful use “more
Physician Owned Hospitals
AAOS helped secure more than 80 cosponsors for the Patient Access to Higher Quality Healthcare Act. The legislation would lift the expansion and new construction restrictions on physician-owned hospitals (POH) that were included in the Affordable Care Act. Similar language was included in Representative Jim Banks’s (R-IN) recently introduced Hospital Competition Act of 2019, which aims to combat the rising cost of health care and is endorsed by the AAOS. Additionally, a Senate companion bill was introduced for the first time for which AAOS helped secure more than 10 original cosponsors.
working with a coalition of orthopaedic practices and the Physician Hospital
Association to develop a demonstration program through the Center for Medicare
and Medicaid Innovation, which would allow POHs to expand. It is also working
at the state level on state action waivers which would also lift the POH
Stark Law Reform
The outdated and cumbersome Stark Law, which restricts physician referrals, needs to be reformed as we move to a value-based reimbursement system. It was designed for a fee-for-service environment and inhibits coordinated care. The AAOS aggressively advocated for the Medicare Care Improvement Act in the House and the Senate, which would provide exceptions from the Stark Law for alternative payment models. AAOS is now working with House and Senate sponsors on a more comprehensive bill for the 116th Congress.
AAOS worked with Representative Burgess (R-TX) to introduce H.R. 880, the MISSION ZERO Act, and the legislation was passed by the U.S. House of Representatives on February 26, 2018. This bill will provide grants and allow Department of Defense trauma surgeons to be assigned to civilian trauma centers. The legislation is intended to help fill gaps in care and ensure that advances in military trauma care are brought home for civilian patients. AAOS, working with the Orthopaedic Trauma Association (OTA), participates in the Trauma Coalition, which worked to formulate and advance this legislation.
The MISSION ZERO Act was placed in the Pandemic and All Hazards Preparedness and Advancing Innovation Act (PAHPAI), a legislative package that was due to be passed by Sept. 30, 2018. The House passed this package, but due to an unrelated dispute among senators the package has not yet been passed in the Senate. AAOS OGR is hopeful action will be taken on this package shortly.
The VA MISSION Act became
law on June 6, 2018 and included AAOS-supported language that ended the effort
to call podiatrists at the VA “physicians” and allow them direct clinical
supervision of MD’s and DO’s. The final language only allows podiatrists a
raise and access to non-clinical leadership positions. The legislation was the
result of months of negotiation between APMA and AAOS, with the full
participation and support of AOFAS. The Joint Task Force of Orthopaedic
Surgeons and Podiatric Surgeons was created to continue these conversations and
accomplish two goals: to allow the organizations to work together on common
issues and to study differences in education to determine whether a path could
exist for podiatrists to be recognized as physicians.
During the 2019 AMA Interim Meeting, the Orthopaedic Section Council– an AAOS-led group of orthopaedic specialty and sub-specialty delegates to the AMA, led by Dr. Michael Suk—worked with Dr. Michael Aronow (AOFAS) to strengthen existing language and ensure physician-led (MD or DO as defined by the AMA) clinical training, supervision, and evaluation while recognizing the contribution of non-physicians to medical education. This passed unanimously and successfully became official AMA policy.
On October 24, 2018, the president signed into law bipartisan legislation to combat the opioid crisis called the SUPPORT Patients and Communities Act (H.R.6). AAOS was successful in ensuring the final agreement included the Every Prescription Conveyed Securely Act (H.R.3528), which will require prescriptions for controlled substances covered under Medicare Part D to be transmitted electronically, beginning January 1, 2021. AAOS supported this legislation and strongly believes that electronic prescribing promotes patient safety and will also provide data in a format that can provide better surveillance of excessive, inappropriate, and non-therapeutic prescribing.
AAOS was also successful in advocating that the final bill authorized Centers for Disease Control and Prevention (CDC) grants to states and localities to improve their Prescription Drug Monitoring Programs (PDMPs), collect public health data, implement other evidence-based prevention strategies, encourage data sharing between states, and support other prevention and research activities. The AAOS supports increased use and interoperability of PDMPs and believes they can help providers make the best clinical decisions for their patients, by providing up-to-date and accurate prescription information.
To read more about the issue of opioids and the FDA, visit: https://www.aaos.org/advocacy/fda/
ASC Transparency Act
The Ambulatory Surgical Center (ASC) Payment Transparency Act of 2018 (H.R. 6138) was passed by the House on July 25, 2018. This bill would add an ASC representative to the Advisory Panel on Hospital Outpatient Payment and would requires that CMS disclose criteria used to determine the ASC Procedure List.
2018 was a historic year for the Orthopaedic Political Action Committee (PAC). In addition to the growth of the Advisors’ Circle and record-breaking resident involvement, the Orthopaedic PAC reached its lofty goal of raising $4 million during the 2018 election cycle. It also had unprecedented access and representation at more than 1,200 political events, an increase of more than 25 percent from last election cycle. The strength of the PAC has allowed orthopaedists to have a seat at the table and educate members of Congress about the importance of musculoskeletal care. On March 5, it was named the 2018 Outstanding Association PAC by the Public Affairs Council at the National PAC Conference in Miami, Fla. The award recognizes an association PAC program that has demonstrated success in implementing a new campaign, strategy, or solicitation to strengthen or grow. Visit the PAC website